Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.
Fernández S, Año G, Castaño J, Pino Y, Uribarri E, Riverón LA, Cedré B, Valmaseda T, Falero G, Pérez JL, Infante JF, García LG, Solís RL, Sierra G, Talavera A. Fernández S, et al. Among authors: solis rl. Travel Med Infect Dis. 2013 Mar-Apr;11(2):103-9. doi: 10.1016/j.tmaid.2012.10.006. Epub 2013 Mar 13. Travel Med Infect Dis. 2013. PMID: 23492079
Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.
Valera R, García HM, Jidy MD, Mirabal M, Armesto MI, Fando R, García L, Fernández R, Año G, Cedré B, Ramírez M, Bravo L, Serrano T, Palma S, González D, Miralles F, Medina V, Nuñez F, Plasencia Y, Martínez JC, Mandarioti A, Lugones J, Rodríguez BL, Moreno A, González D, Baro M, Solis RL, Sierra G, Barbera R, Domínguez F, Gutiérrez C, Kouri G, Campa C, Menéndez J. Valera R, et al. Among authors: solis rl. Vaccine. 2009 Nov 5;27(47):6564-9. doi: 10.1016/j.vaccine.2009.08.042. Epub 2009 Aug 29. Vaccine. 2009. PMID: 19720365 Clinical Trial.
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
Pérez O, Bracho G, Lastre M, Zayas C, González D, Gil D, del Campo J, Acevedo R, Taboada C, Rodríguez T, Fajardo ME, Sierra G, Campa C, Mora N, Barberá R, Solís RL. Pérez O, et al. Among authors: solis rl. Vaccine. 2006 Apr 12;24 Suppl 2:S2-52-3. doi: 10.1016/j.vaccine.2005.01.127. Vaccine. 2006. PMID: 16823925
New vaccines require potent adjuvants like AFPL1 and AFCo1.
Pérez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, Balboa J, Acevedo R, Zayas C, Gil D, Mora N, González D, Pérez R, González E, Barberá R, Fajardo EM, Sierra G, Solís RL, Campa C. Pérez O, et al. Among authors: solis rl. Scand J Immunol. 2007 Aug-Sep;66(2-3):271-7. doi: 10.1111/j.1365-3083.2007.01981.x. Scand J Immunol. 2007. PMID: 17635804 Free article.
23 results